1[1]Kleeff J, Friess H, Berberat PO et al. Pancreatic cancer-new aspects of molecular bioloty research. Swiss Surg,2000;6(5):231～234
2[2]Villeneuve PJ, Johnson KC, Hanley AJ et al. Alcohol, tobacco and coffee consumption and the risk of pancreatic cancer: results from the Canadian Enhanced Surveillance System case-control project. Eur J Cancer Prev,2000;9(1):49～58
3[3]Rayford PL. Alcohol, tobacco (nicotine) and pancreatic pathophysiology. J Assoc Acad Minor Phys,2001;12(1-2):91～94
4[4]Stolzenberg-Solomon RZ, Albanes D, Nieto FJ et al. Pancreatic cancer risk and nutrition-related methyl-group availability indicators in male smokers.J Natl Cancer Inst,1999;91(6):535～541
5[5]Soler M, Chatenoud L,La Vecchia C et al. Diet, alcohol, coffee and pancreatic cancer:final results from an Italian study.Eur J Cancer Prev.1998;7(6):455～460
6[6]Silverman DT, Swanson CA, Gridley G et al. Dietary and nutritional factors and pancreatic cancer:a case-control study based on direct interviews.J Natl Cancer Inst,1998;90(22):1710～1719
7[7]Michaud DS,Giovannucci E,Willett WC.Coffee and alcohol consumption and the risk of pancreatic cancer in two prospective United States cohorts.Cancer Epidemiol Biomarkers Prev,2001;10(5):429～437
8[8]Ojajarvi IA,Partanen TJ,Ahlbom A et al. Occupational exposures and pancreatic cancer:a meta-analysis.Occup Environ Med,2000;57(5):316～324
9[9]Talamini G,Falcone M,Bassi C et al. Incidence of cancer in the course of chronec pancreatitis.Am J Gastroenterol,1999;94:1253～1260
10[10]Etemad B,Whitcomb DC. Chronic pancreatitis: diagnosis, classification,and new genetic developments.Gastroenterology,2001;120:682～707
2Lowenfels AB, Maisonneuve P. Epidemiology and prevention of pancreatic cancer[J]. Jpn J Clin Oncol, 2004,84 (5) :238.
3Arlt A,Gehrz A, Muerkoster S, et al. Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death[J]. Oncogene,2003,22(21) :3243.
4El Maalouf G, Le Tourneau C, Batty GN,et al. Markers involved in resistance to cytotoxics and targeted therapeutics in pancreatic cancer[J]. Cancer Treat Rev, 2009,35(2):167.
5di Palma A, Matarese G, Leone V, et al. Aspirin reduces the outcome of antieaneer therapy in Meth A hearing mice through activation of AKT glycogen synthase kinase signaling[J]. Mol Cancer Ther,2006,5(5) : 1318.
6I.i L,Aggarwal BB,Shishodia S,et al. Nuclear factor-kappaB and IkappaB kinase are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis [J]. Cancer, 2004,101(10) :2351.
7Gilroy DW. The role of aspirin-triggered lipoxins in the mechanism of action of aspirin[J]. Prostaglandins Leukot Essent Fatty Acids, 2005,73 (3-4) :203.
8Ricchi P, Palma AD, Matola TD, et al. Aspirin protects Caco-2 cells from apoptosis after serum deprivation through the activation of a phosphatidylinositol 3-kinase/ AKT/p21Cip/WAFlpathway[J]. Mol Pharmacol, 2003, 64(2) ,407.
9Wendel HG, De Stanchina E, Fridman JS, et al. Survival sig nailing by Akt and eIF4E in oncogenesis and cancer therapy [J]. Nature,2004,428(6980) :332.
